Medical News

---

• Novel HIT treatment approach proposed
• Long-term prognosis poor after SVD stroke
• Start dose for UV-B psoriasis treatment important for tolerance, not efficacy
• Educational intervention improves SCC detection in kidney transplant recipients
• Cannabis ingredient could help cancer patients eat again
• Patients with high CV risk need ‘more aggressive treatment’
• Novel variable aids CVD risk identification
• Long-term prognosis poor after SVD stroke
• ESRD risk in Type 1 diabetes remains high despite increased treatment
• High blood glucose predicts in-hospital mortality in elderly nondiabetics
• Air pollution may raise MI risk
• A drink a day may keep the cardiologist away

Novel HIT treatment approach proposed Posted: 24 Feb 2011 04:00 PM PST US researchers have developed a novel selective tyrosine kinase inhibitor that prevents both heparin-induced thrombocytopenia antibody-mediated platelet activation in vitro, and thrombocytopenia and thrombosis in vivo.

Long-term prognosis poor after SVD stroke Posted: 24 Feb 2011 04:00 PM PST Stroke patients with small-vessel disease have worse survival rates than those with other stroke etiologies, shows a long-term study.

Start dose for UV-B psoriasis treatment important for tolerance, not efficacy Posted: 24 Feb 2011 04:00 PM PST Determining the appropriate dose of narrowband ultraviolet-B treatment for psoriasis patients by first working out their minimal erythemal dose does not affect treatment efficacy, but is important for identifying adverse effects, say researchers.

Educational intervention improves SCC detection in kidney transplant recipients Posted: 24 Feb 2011 04:00 PM PST An educational intervention to increase awareness about squamous cell carcinoma (SCC) effectively increases skin self-examination and dermatologist follow-up of suspect lesions in kidney transplant recipients, say researchers.

Cannabis ingredient could help cancer patients eat again Posted: 24 Feb 2011 04:00 PM PST Advanced cancer patients with a poor appetite and chemosensory alterations could have their symptoms improved by treatment with delta-9-tetrahydrocannabinol, an ingredient of cannabis, show study findings.

Patients with high CV risk need ‘more aggressive treatment’ Posted: 24 Feb 2011 04:00 PM PST National Cholesterol Education Program Adult Treatment Panel-III guidelines for non high-density lipoprotein cholesterol may fail to optimize cardiovascular risk reduction among high- and intermediate-risk patients, say researchers.

Novel variable aids CVD risk identification Posted: 24 Feb 2011 04:00 PM PST Spanish researchers have proposed an alternative to the metabolic syndrome for detecting individuals at risk for cardiovascular disease and Type 2 diabetes.

Long-term prognosis poor after SVD stroke Posted: 24 Feb 2011 04:00 PM PST Stroke patients with small-vessel disease have worse survival rates than those with other stroke etiologies, shows a long-term study.

ESRD risk in Type 1 diabetes remains high despite increased treatment Posted: 24 Feb 2011 04:00 PM PST Patients with Type 1 diabetes and macroalbuminuria remain at high risk for end stage renal disease despite significant improvements in treatment and renoprotection over the last 2 decades, say US researchers.

High blood glucose predicts in-hospital mortality in elderly nondiabetics Posted: 24 Feb 2011 04:00 PM PST Having a high serum glucose level on admission to hospital is a significant predictor of in-hospital mortality in nondiabetic elderly patients, suggest study results.

Air pollution may raise MI risk Posted: 24 Feb 2011 04:00 PM PST Researchers report that exposure to air pollution may raise an individual's risk for myocardial infarction by a size similar to that associated with established risk factors, such as physical exertion and coffee consumption.

A drink a day may keep the cardiologist away Posted: 24 Feb 2011 04:00 PM PST Findings from two meta-analyses suggest that individuals who consume one alcoholic drink a day may have a lower risk for heart disease than teetotallers.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610